Deep learning detection of informative features in tau PET for Alzheimer’s disease classification
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2105
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Deep learning detection of informative features in tau PET for Alzheimer’s disease classification ; volume:21 ; number:21 ; day:28 ; month:12 ; year:2020 ; pages:1-13 ; date:12.2020
BMC bioinformatics ; 21, Heft 21 (28.12.2020), 1-13, 12.2020
- Urheber
-
Jo, Taeho
Nho, Kwangsik
Risacher, Shannon L.
Saykin, Andrew J.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12859-020-03848-0
- URN
-
urn:nbn:de:101:1-2021020118210134135308
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Jo, Taeho
- Nho, Kwangsik
- Risacher, Shannon L.
- Saykin, Andrew J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
CYP1B1-RMDN2 Alzheimer’s disease endophenotype locus identified for cerebral tau PET
Characterization of Alzheimer’s tau biomarker discordance using plasma, CSF, and PET
Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer’s disease
Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease
Cryo-EM structure of Alzheimer’s disease tau filaments with PET ligand MK-6240
Tau PET correlates with different Alzheimer’s disease‐related features compared to CSF and plasma p‐tau biomarkers
Cryo-EM structures of tau filaments from Alzheimer’s disease with PET ligand APN-1607
Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer’s disease spectrum
Imaging in-vivo tau pathology in Alzheimer’s disease with THK5317 PET in a multimodal paradigm
Baseline [18F]GTP1 tau PET imaging is associated with subsequent cognitive decline in Alzheimer’s disease
International consensus on the use of tau PET imaging agent 18F-flortaucipir in Alzheimer’s disease
Characterization of MK6240, a tau PET tracer, in autopsy brain tissue from Alzheimer’s disease cases
CYP1B1-RMDN2 Alzheimer’s disease endophenotype locus identified for cerebral tau PET
Characterization of Alzheimer’s tau biomarker discordance using plasma, CSF, and PET
Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer’s disease
Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease
Cryo-EM structure of Alzheimer’s disease tau filaments with PET ligand MK-6240
Tau PET correlates with different Alzheimer’s disease‐related features compared to CSF and plasma p‐tau biomarkers
Cryo-EM structures of tau filaments from Alzheimer’s disease with PET ligand APN-1607
Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer’s disease spectrum
Imaging in-vivo tau pathology in Alzheimer’s disease with THK5317 PET in a multimodal paradigm
Baseline [18F]GTP1 tau PET imaging is associated with subsequent cognitive decline in Alzheimer’s disease
International consensus on the use of tau PET imaging agent 18F-flortaucipir in Alzheimer’s disease
Characterization of MK6240, a tau PET tracer, in autopsy brain tissue from Alzheimer’s disease cases
CYP1B1-RMDN2 Alzheimer’s disease endophenotype locus identified for cerebral tau PET
Characterization of Alzheimer’s tau biomarker discordance using plasma, CSF, and PET
Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer’s disease
Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease
Cryo-EM structure of Alzheimer’s disease tau filaments with PET ligand MK-6240
Tau PET correlates with different Alzheimer’s disease‐related features compared to CSF and plasma p‐tau biomarkers
Cryo-EM structures of tau filaments from Alzheimer’s disease with PET ligand APN-1607
Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer’s disease spectrum
Imaging in-vivo tau pathology in Alzheimer’s disease with THK5317 PET in a multimodal paradigm
Baseline [18F]GTP1 tau PET imaging is associated with subsequent cognitive decline in Alzheimer’s disease
International consensus on the use of tau PET imaging agent 18F-flortaucipir in Alzheimer’s disease